13-04-2025 22:09 via medpagetoday.com

Pridopidine Shows Promise in Subgroup of Huntington's Patients

(MedPage Today) -- SAN DIEGO--Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according to subgroup analysis of the PROOF-HD trial.
Those improvements were seen in terms of...
Read more »

Medical Industry news



The Power of Film to Change Medical Culture
Registry Data Reassure on JAK Inhibitors' Heart Risks
More People Are Obtaining Abortions but Fewer Are Traveling to Other States
I Survived Leukemia Because of a Clinical Trial. Will Future Patients Be So Lucky?
Read the Results of Trump's 2025 Physical Exam
The Choice Between Chemotherapy and Targeted Therapy in Pediatric Low-Grade Glioma
Vaccine Advisors to Meet; Donated Organs Left Unused; Counterfeit Ozempic Warning
Study Pinpoints Barriers to Kids Receiving Living-Donor Kidney Transplants
Docs Decry Optum's Tactics for Collecting Loan Repayments From Change Cyberattack
Emergency Care for Cannabis Use Tied to Higher Dementia Risk
Months After CEO's Killing, Intruder Arrested Near UnitedHealthcare's Headquarters
A Reported Intruder Is Arrested Near UnitedHealthcare Headquarters
Will Memoli Be the Next NIAID Director?
Another Push for Upfront Ezetimibe-Statin Combo Soon After MI
Desktop versie